Loading...
Not a good buy right now. QNRX is extremely oversold and could bounce short-term, but there are no Intellectia buy signals, no news catalysts, and the fundamentals remain weak (no revenue, large losses). For an impatient buyer unwilling to wait for an optimal setup, the odds favor a low-quality entry rather than a high-conviction buy.
Trend/Momentum: Bearish but potentially near an exhaustion point. MACD histogram is -0.2 (below zero) but negatively contracting, implying downside momentum is weakening. RSI(6) at 8.45 signals extreme oversold conditions, which can precede a reflex bounce. Key levels: Current price 7.97 is below S1 (8.489) and just above S2 (7.84). A clean break below ~7.84 would be technically negative. Upside reclaim targets are S1 ~8.49, then Pivot ~9.54; resistance levels above are R1 ~10.59 and R2 ~11.239. Moving averages: Converging MAs suggest compression, but without a catalyst this is not a reliable reversal signal. Pattern-based forward look: Similar-pattern stats imply modest upside bias over 1 week/month (next week +0.63%, next month +4.39%), but near-term signal quality is weak.
Intellectia Proprietary Trading Signals: Intellectia Proprietary Trading Signals
can trigger a short-term mean-reversion bounce.
and near S2 (7.84), indicating fragile structure and risk of another leg down if S2 breaks.
Latest reported quarter: 2025/Q3. Revenue remains 0 (0.00% YoY). Net income improved to -3,948,165 (+68.02% YoY improvement), but EPS fell to -6.71 (-58.81% YoY), indicating per-share losses worsened despite net loss improvement (likely influenced by share count/other items). Overall: still pre-revenue with material losses, so fundamentals do not support a strong ‘buy now’ case.
No analyst rating or price target change data provided, so Wall Street pros/cons cannot be confirmed from the dataset. Based on the provided information alone: Pros would be any oversold technical rebound potential; cons are pre-revenue status, ongoing losses, and lack of visible catalysts.
